Amgen stock last at USD 410.86, up 1.19 percent in New York trading
Published on 09/25/2026 at 20:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen stock was last at USD 410.86 in New York trading on September 25, 2026, up USD 4.82 or 1.19 percent from the USD 406.04 prior reference. The advance outpaced the S&P 500's 0.53 percent gain reported during the session. Amgen was last quoted at 1:17:34 p.m. ET, with regular New York trading still under way at that time.
The session on September 25, 2026 in figures
Amgen Inc. (ISIN US0311621009) opened at USD 408.25 on Nasdaq, above the USD 406.04 prior reference. The stock reached a session high of USD 411.00 and a low of USD 404.19. Trading volume stood at 684,284 shares at 1:17:34 p.m. ET, while the shares traded USD 36.17 below the 52-week high of USD 447.03.
Amgen's USD 6.81 intraday range ran from USD 404.19 to USD 411.00. The latest USD 410.86 level sat USD 0.14 below the session high and USD 6.67 above the session low. The stock remained USD 141.09 above its 52-week low of USD 269.77.
Market gains met elevated long term yields
Amgen's 1.19 percent advance exceeded the S&P 500's 0.53 percent rise by 0.66 percentage points. As Yahoo Finance reported on September 25, 2026, stocks edged higher as oil prices declined. The report put the 10-year Treasury yield at 5.225 percent and the 30-year yield at 5.502 percent.
The S&P 500 stood at 7,744.93, up 0.53 percent, while the Dow 30 reached 51,804.58, up 0.89 percent. The Nasdaq was at 27,107.95, up 0.63 percent, during the report's September 25 market update. The market backdrop combined solid corporate profits with geopolitical risk and monetary-policy uncertainty, according to Yahoo Finance.
Healthcare peers and broader market conditions on September 25, 2026
Moderna traded at USD 197.66, up USD 2.84 or 1.46 percent, in the healthcare comparison published by Yahoo Finance. Amgen's 1.19 percent gain trailed Moderna by 0.27 percentage points. The STOXX 600 rose 0.4 percent in Europe as energy shares fell 1.3 percent and banks gained 1.3 percent, according to Reuters. The report said easing oil prices outweighed continuing uncertainty around Middle East developments and higher bond yields.
Amgen's latest USD 410.86 level was USD 36.17 below the 52-week high and USD 141.09 above the 52-week low. The share price also stood USD 0.14 below its session high of USD 411.00. Forbes listed a consensus recommendation of Hold and a consensus price of USD 389.22, based on its September 25 market data.
